Cargando…

Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: A qualitative study

BACKGROUND: Patients' values and preferences are fundamental tenets of evidence-based practice, yet current osteoporosis (OP) clinical guidelines pay little attention to these issues in therapeutic decision making. This may be in part due to the fact that few studies have examined the factors t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sale, Joanna EM, Gignac, Monique A, Hawker, Gillian, Frankel, Lucy, Beaton, Dorcas, Bogoch, Earl, Elliot-Gibson, Victoria
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103493/
https://www.ncbi.nlm.nih.gov/pubmed/21554729
http://dx.doi.org/10.1186/1471-2474-12-92
_version_ 1782204527295856640
author Sale, Joanna EM
Gignac, Monique A
Hawker, Gillian
Frankel, Lucy
Beaton, Dorcas
Bogoch, Earl
Elliot-Gibson, Victoria
author_facet Sale, Joanna EM
Gignac, Monique A
Hawker, Gillian
Frankel, Lucy
Beaton, Dorcas
Bogoch, Earl
Elliot-Gibson, Victoria
author_sort Sale, Joanna EM
collection PubMed
description BACKGROUND: Patients' values and preferences are fundamental tenets of evidence-based practice, yet current osteoporosis (OP) clinical guidelines pay little attention to these issues in therapeutic decision making. This may be in part due to the fact that few studies have examined the factors that influence the initial decision to take OP medication. The purpose of our study was to examine patients' experiences with the decision to take OP medication after they sustained a fracture. METHODS: A phenomenological qualitative study was conducted with outpatients identified in a university teaching hospital fracture clinic OP program. Individuals aged 65+ who had sustained a fragility fracture within 5 years, were 'high risk' for future fracture, and were prescribed OP medication were eligible. Analysis of interview data was guided by Giorgi's methodology. RESULTS: 21 patients (6 males, 15 females) aged 65-88 years participated. All participants had low bone mass; 9 had OP. Fourteen patients were taking a bisphosphonate while 7 patients were taking no OP medications. For 12 participants, the decision to take OP medication occurred at the time of prescription and involved minimal contemplation (10/12 were on medication). These patients made their decision because they liked/trusted their health care provider. However, 4/10 participants in this group indicated their OP medication-taking status might change. For the remaining 9 patients, the decision was more difficult (4/9 were on medication). These patients were unconvinced by their health care provider, engaged in risk-benefit analyses using other information sources, and were concerned about side effects; 7/9 patients indicated that their OP medication-taking status might change at a later date. CONCLUSIONS: Almost half of our older patients who had sustained a fracture found the decision to take OP medication a difficult one. In general, the decision was not considered permanent. Health care providers should be aware of their potential role in patients' decisions and monitor patients' decisions over time.
format Text
id pubmed-3103493
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31034932011-05-28 Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: A qualitative study Sale, Joanna EM Gignac, Monique A Hawker, Gillian Frankel, Lucy Beaton, Dorcas Bogoch, Earl Elliot-Gibson, Victoria BMC Musculoskelet Disord Research Article BACKGROUND: Patients' values and preferences are fundamental tenets of evidence-based practice, yet current osteoporosis (OP) clinical guidelines pay little attention to these issues in therapeutic decision making. This may be in part due to the fact that few studies have examined the factors that influence the initial decision to take OP medication. The purpose of our study was to examine patients' experiences with the decision to take OP medication after they sustained a fracture. METHODS: A phenomenological qualitative study was conducted with outpatients identified in a university teaching hospital fracture clinic OP program. Individuals aged 65+ who had sustained a fragility fracture within 5 years, were 'high risk' for future fracture, and were prescribed OP medication were eligible. Analysis of interview data was guided by Giorgi's methodology. RESULTS: 21 patients (6 males, 15 females) aged 65-88 years participated. All participants had low bone mass; 9 had OP. Fourteen patients were taking a bisphosphonate while 7 patients were taking no OP medications. For 12 participants, the decision to take OP medication occurred at the time of prescription and involved minimal contemplation (10/12 were on medication). These patients made their decision because they liked/trusted their health care provider. However, 4/10 participants in this group indicated their OP medication-taking status might change. For the remaining 9 patients, the decision was more difficult (4/9 were on medication). These patients were unconvinced by their health care provider, engaged in risk-benefit analyses using other information sources, and were concerned about side effects; 7/9 patients indicated that their OP medication-taking status might change at a later date. CONCLUSIONS: Almost half of our older patients who had sustained a fracture found the decision to take OP medication a difficult one. In general, the decision was not considered permanent. Health care providers should be aware of their potential role in patients' decisions and monitor patients' decisions over time. BioMed Central 2011-05-09 /pmc/articles/PMC3103493/ /pubmed/21554729 http://dx.doi.org/10.1186/1471-2474-12-92 Text en Copyright ©2011 Sale et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sale, Joanna EM
Gignac, Monique A
Hawker, Gillian
Frankel, Lucy
Beaton, Dorcas
Bogoch, Earl
Elliot-Gibson, Victoria
Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: A qualitative study
title Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: A qualitative study
title_full Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: A qualitative study
title_fullStr Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: A qualitative study
title_full_unstemmed Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: A qualitative study
title_short Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: A qualitative study
title_sort decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: a qualitative study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103493/
https://www.ncbi.nlm.nih.gov/pubmed/21554729
http://dx.doi.org/10.1186/1471-2474-12-92
work_keys_str_mv AT salejoannaem decisiontotakeosteoporosismedicationinpatientswhohavehadafractureandarehighriskforfuturefractureaqualitativestudy
AT gignacmoniquea decisiontotakeosteoporosismedicationinpatientswhohavehadafractureandarehighriskforfuturefractureaqualitativestudy
AT hawkergillian decisiontotakeosteoporosismedicationinpatientswhohavehadafractureandarehighriskforfuturefractureaqualitativestudy
AT frankellucy decisiontotakeosteoporosismedicationinpatientswhohavehadafractureandarehighriskforfuturefractureaqualitativestudy
AT beatondorcas decisiontotakeosteoporosismedicationinpatientswhohavehadafractureandarehighriskforfuturefractureaqualitativestudy
AT bogochearl decisiontotakeosteoporosismedicationinpatientswhohavehadafractureandarehighriskforfuturefractureaqualitativestudy
AT elliotgibsonvictoria decisiontotakeosteoporosismedicationinpatientswhohavehadafractureandarehighriskforfuturefractureaqualitativestudy